Currently, Paul Roger Perreault is Chief Executive Officer, Executive Director & MD at CSL Ltd. In his past career he held the position of Chairman-Global Board at Plasma Protein Therapeutics Association, Chief Executive Officer & Managing Director at CSL Behring LLC, Vice President & General Manager at Aventis Behring, Business Director at Wyeth-Ayerst Research and Vice President & General Manager at Aventis Bio-Services, Inc. Mr. Perreault received an undergraduate degree from the University of Central Florida.